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Protein–RNA interactions within ribonucleoprotein particles (RNPs) can be investigated by
UV-induced crosslinking of proteins to their cognate RNAs and subsequent isolation and
mass-spectrometric analysis of crosslinked peptide–RNA oligonucleotides. Because of the low
crosslinking yield, a major challenge in protein–RNA UV crosslinking is the detection of the
crosslinked species over the excess of non-crosslinked material, especially when complex
systems (native RNPs) are investigated. Here, we applied a novel approach that uses on-line
nanoLC-ESI-MS/MS to detect and subsequently sequence peptide–RNA oligonucleotide
crosslinks from crude mixtures. To detect the crosslinks we made use of features shared by
crosslinks and phosphopeptides, that is, the phosphate groups that both carry. A precursor ion
scan for m/z 79 (negative-ion mode, ve) is applied to selectively detect analytes bearing the
phosphate-containing species (i.e., residual non-crosslinked RNA and peptide–RNA
crosslinks) from crude mixtures and to determine their exact m/z values. On this basis, a
multiple reaction monitoring (MRM) experiment monitors the expected decomposition from
the different precursor charge states of the putative crosslinks to one of the four possible RNA
nucleobases [m/z 112, 113, 136, 152 (positive-ion mode, ve)]. On detection, a high-quality
MS/MS is triggered to establish the structure of the crosslink. In a feasibility study, we
detected and subsequently sequenced peptide–RNA crosslinks obtained by UV-irradiation of
(1) native U1 snRNPs and (2) [15.5K-61K-U4atac] snRNPs prepared by reconstitution in vitro.
MRM-triggered collision-induced dissociation (CID) MS/MS enabled us to obtain sequence
information about the crosslinked peptide and RNA moiety. (J Am Soc Mass Spectrom 2007,
18, 869–881) © 2007 American Society for Mass SpectrometryRNA and protein–RNA complexes (ribonucleo-protein particles, RNPs) are just as crucial in thecontrol and regulation of gene expression in the
eukaryotic cell as are protein–DNA complexes (tran-
scriptomes). Very recent investigations, such as in the
field of alternative splicing regulation and of transla-
tional control by microRNAs (miRNA), have demon-
strated impressively that protein–RNA interactions and
their dynamic changes are the complex driving forces
behind these processes (for review, see Blencowe [1]
and Bartel [2]).
Numerous MS-based proteomic approaches deter-
mined which proteins are associated with RNA [3–7].
However, these studies have yielded only limited infor-
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doi:10.1016/j.jasms.2007.01.013mation about which protein is in direct contact with the
RNA. A straightforward method to determine this is
crosslinking.
Crosslinking between RNA and proteins can be
achieved in different ways: (1) by incorporating base
analogues (e.g., 5-bromo-2=-deoxyuridine [8], iodo-
derivatives [9, 10], or 4-thio-uracil [11–13]) into the
RNA, either site-specifically or randomly; (2) by chem-
ical modification of the RNA backbone (acidophenacyl
and benzophenone [14, 15]) (3) by incubating protein–
RNA assemblies with crosslinking reagents (e.g., form-
aldehyde [16], methylene blue [17], and cis-platin [18]);
or (4) by direct UV-irradiation at 254-nm wavelength
[19]. The latter method uses the naturally occurring UV
reactivity of the RNA nucleobases and has been suc-
cessfully applied to various native protein–RNA com-
plexes isolated from living cells [20 –22].
Once the crosslink has been established, the main
challenge is the identification of the crosslinked protein.
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robust methods, such as strongly binding antibodies.
Immunoprecipitation of crosslinked protein–nucleic
acid complexes has been successfully applied to the
analysis of the interacting nucleotide parts and is man-
ifested in generally applicable approaches like chroma-
tin immunoprecipitation (ChIP) [23, 24], crosslinking
and immunoprecipitation (CLIP) [25], and/or (chroma-
tin) immunoprecipitation followed by DNA microarray
analysis [(Ch)IP-chip] [26, 27]. However, these ap-
proaches presuppose knowledge of an interacting pro-
tein or factor and are thus hypothesis-driven. Conse-
quently, the identification of hitherto unknown
crosslinked proteins requires other protein-analytical
methods, of which mass spectrometry is the most
sensitive technique currently available.
Protein–nucleic acid crosslinks have been investi-
gated by mass spectrometry in several laboratories. In
pioneering studies, Jensen et al. [28] and Steen et al. [29]
demonstrated the mass spectrometric analysis of peptide–
DNA oligonucleotides by matrix-assisted laser desorp-
tion/ionization (MALDI) and electrospray ionization
(ESI), respectively. Other studies of protein–nucleic acid
crosslinks using mass spectrometry followed [9, 10,
30 –33].
We are particularly interested in the characterization
of peptide–RNA conjugates from native protein–RNA
complexes isolated from a living cell. This demands
highly sensitive methods.
We therefore established in previous studies a puri-
fication strategy that enabled us to isolate crosslinked
peptide–RNA oligonucleotides from native and recon-
stituted ribonucleoprotein particles after UV-irradiation
([22] and below). Our approach consists of hydrolysis of
the protein and RNA moieties (with endoproteinases
and endonucleases, respectively) and purification of the
crosslinked peptide–RNA oligonucleotides by micro-
bore and/or capillary reversed-phase (RP) liquid chro-
matography (LC). Thereafter, MALDI–MS and –MS/MS
(tandem mass spectrometric) analysis of the isolated
crosslinks provide structural information about the
crosslinked peptide and RNA moieties.
Because the crosslinking yield is very low, especially
when the natural UV reactivity of the RNA nucleobases
is used, a successful mass spectrometric analysis of
crosslinked proteins must meet challenges similar to
those encountered in the detection of post-translational
modifications: (1) Enrichment of the crosslinked (mod-
ified) species over the excess of non-crosslinked (non-
modified) material, (2) identification of the crosslinked
(modified) species and exclusion of false positives, and
(3) the application of mass spectrometric analysis per se.
To detect and sequence peptide–RNA oligonucleo-
tide heteroconjugates derived from UV-irradiated RNP
particles, we make use of features shared by protein–
RNA crosslinks and phosphopeptides. Both species
carry phosphate groups, a feature that can be used to
detect them in crude protein/peptide mixtures. Much
effort is currently being devoted to enrichment strate-gies for phosphopeptides by affinity chromatography
(for review, see Jensen [34] and Corthals et al. [35]).
Alternatively, experiments using mass spectrometry
alone (i.e., constant neutral loss, precursor ion scan, and
multiple reaction monitoring) have also been success-
fully performed to selectively detect and subsequently
sequence phosphopeptides [36 –39]. In particular, mul-
tiple reaction monitoring (MRM)–driven LC/MS/MS
experiments on hybrid triple quadrupole/linear ion-
trap instruments are highly sensitive techniques that
allow one to identify modified components of low
abundance in complex mixtures. Although MRM is a
targeted technique, it can nonetheless be applied for the
detection of hitherto unknown compounds if a suffi-
cient amount of starting information is available to form
a hypothesis about a set of putative analytes. Cox et al.
[40] and Unwin et al. [41] demonstrated the detection of
low-abundance phosphorylation events using only the
amino acid sequence of the protein concerned as a
starting point.
In this study, we set up a strategy for crosslink
analysis based on nanoLC-ESI-MS/MS using precursor
ion scanning and MRM experiments. In a feasibility
study, we successfully detected and identified several
peptide–RNA oligonucleotide crosslinks derived from
(1) native U1 small nuclear ribonucleoprotein (snRNP)
particles [42] and (2) [15.5K-61K-U4atac snRNA] com-
plexes [43]. These U snRNPs are subcomplexes of the
human major and minor spliceosome, respectively;
each of these spliceosomes is a large protein–RNA
machinery that catalyzes removal of the introns from
pre-mRNAs and subsequent ligation of the exons to
yield mature mRNAs (for review, see Will and Lühr-
mann [44]). U1 snRNP particles consist of a small
uridine-rich RNA (U1 snRNA) and ten proteins (70K, A
and C protein and the seven Sm-proteins B/B=, D1, D2,
D3, E, F, and G), whereas the [15.5K-61K-U4atac
snRNA] complexes reconstituted in vitro consist of the
U4atac snRNA and the evolutionarily conserved pro-
teins 15.5K [45] and 61K [46].
Experimental
Sample Preparation, Crosslinking, and Purification
of Peptide–RNA Oligonucleotide Crosslinks
Native U1 snRNP and [15.5K-61K-U4atac snRNA] par-
ticles generated by reconstitution in vitro were pre-
pared as described previously [42, 43]. UV crosslinking
of samples was carried out at 254 nm for 2 min
according to Kühn-Hölsken et al. [22]. A total of 50
pmol of crosslinked sample was denatured in the pres-
ence of 6 M guanidine hydrochloride (guanidine-HCl)
in 50 mM Tris-(hydroxymethyl)aminomethane (Tris–
HCl) (pH 8.0), heated for 5 min at 90 °C, cooled to room
temperature, diluted with 50 mM Tris-HCl (pH 8.0) to 1
M guanidine-HCl, and incubated overnight at 37 °C
with trypsin or chymotrypsin at an enzyme-to-substrate
ratio of 1:20. Trypsin and chymotrypsin were tested for
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with 3 volumes of ethanol and 1/10 volume of 3.0 M
sodium acetate pH 5.3; dissolved in a buffer containing
150 mM sodium chloride, 50 mM Tris–HCl (pH 7.5), 1
mM ethylendiamine tetraacetate (EDTA), and 0.1% so-
dium dodecylsulfate (SDS); and loaded onto a Seph-
adex 75HR size-exclusion column (GE Healthcare, 32 
0.5 cm) mounted in a SMART system (GE Healthcare).
Fractions containing RNA were precipitated with etha-
nol as above and dissolved in a buffer containing 50
mM Tris-HCl (pH 7.5) and 1 mM EDTA. RNA was
hydrolyzed with 1–2 g RNase A and/or T1 (Ambion)
for 2 h at 52 °C. Residual longer peptides were again
hydrolyzed with 1 g of the respective endoproteinases
at 37 °C overnight. Aliquots (10–20 L) of the crude
crosslinked mixture were stored at 20 °C for nanoLC
separation.
NanoLC/MS/MS Analysis of Mixtures Containing
Crosslinks
Mixtures containing peptide–RNA oligonucleotide
crosslinks were separated on a Tempo 1D nanoLC
system (Applied Biosystems/MDS Sciex). Ten percent
of the preparation to be analyzed (nominal 5 pmol
when referring to the amount of starting material used
for the experiments) was injected onto a PepMap RP-
C18 trap column (5  300 m, 5 Å, Dionex), purified,
and desalted with an extended washing time to reduce
the content of pure RNA compounds [0.5% (vol/vol)
formic acid (FA)/2% (vol/vol) CH3CN, 20 L/min, 8
min). Separation was achieved by back-flush gradient
elution onto a PepMap C18 microcolumn [15 cm  75
m, 3 Å; 90-min linear gradient 5–40% (vol/vol)
CH3CN/0.1% (vol/vol) FA, 300 nL/min]. The eluent
was analyzed in a 4000 Q TRAP LC/MS/MS system
Table 1. Example of the calculation of MRM transitions from pr
irradiated native U1 snRNP particles after hydrolysis with trypsi
Precursor ion scan m/z 79
[M-2H]2 RT (min) MW (Da)
961.4 25.0 1924.8
883.3 31.0 1768.7using a Microionspray source and a nano-desolvationchamber interface (nanoDCI). Analyst 1.4.1 and Bioana-
lyst 1.4.1 software (all Applied Biosystems/MDS Sciex)
were used for acquisition control, information-
dependent experiments, and data processing.
Precursor Ion Scanning Experiments
Peptide–RNA oligonucleotide crosslinks and RNA
oligonucleotides were selectively detected using a
precursor ion scan experiment for m/z 79 (PO3
). The
400–1800 m/z range was scanned using a scan time of
5 s and a rolling collision energy of (0.04 m/z  9) V.
The most abundant signals detected in the precursor
ion scan (up to five signals) were then submitted to a
high-resolution linear ion-trap MS scan in negative-
ion mode to determine unambiguously their charge
state and molecular weight (MW). The longest cycle
time was 6 s. The linear ion-trap scans were then
charge-state deconvoluted to yield a “molecular
weight versus retention time” map (“heat map”) of
the putative crosslinks in each sample.
Multiple Reaction Monitoring Experiments
Fragmentation reactions were predicted based on (1)
each putative crosslink being present as either
[M2H]2 or [M3H]3; (2) a Q2 collision energy of 65
and 100 V for triply and doubly charged precursors,
respectively; and (3) the generation of RNA nucleobase-
specific fragments m/z 112 (C), 113 (U), 136 (A), and 152
(G). MRM transitions were set up in positive-ion mode
(ve) for each of these fragmentations and monitored
throughout the gradient using unit resolution in Q1 and
Q3, and dwell times of 30 – 60 ms per transition. Table 1
shows an example of the design of MRM transitions.
Two doubly charged precursors were detected in the
sors detected in the precursor ion scanning experiment of UV-
RNase T1
MRM to RNA nucleobase
m/z Q1 CE (V) m/z Q3
642.6 (3) 65 112.0 (C)
642.6 (3) 65 113.0 (U)
642.6 (3) 65 136.0 (A)
642.6 (3) 65 152.0 (G)
963.4 (2) 100 112.0 (C)
963.4 (2) 100 113.0 (U)
963.4 (2) 100 136.0 (A)
963.4 (2) 100 152.0 (G)
590.5 (3) 65 112.0 (C)
590.5 (3) 65 113.0 (U)
590.5 (3) 65 136.0 (A)
590.5 (3) 65 152.0 (G)
885.3 (2) 100 112.0 (C)
885.3 (2) 100 113.0 (U)
885.3 (2) 100 136.0 (A)
885.3 (2) 100 152.0 (G)ecur
n andnegative-mode precursor ion scanning experiment for
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These two precursors were translated into a panel of 16
MRM transitions, accounting for doubly/triply charged
precursors and the four expected nucleobase marker
fragments in the positive-ion mode MRM experiment.
On exceeding a threshold value on one of the MRM
transitions, up to two high-resolution MS and up to two
full product ion scans in positive-ion mode were trig-
gered. A dynamic subtraction of the MRM background
was used, to ensure that MS/MS was performed close to
the apex of the chromatographic profile for each precur-
sor. Product ion scans were performed by using isolation
of the precursor in Q1 at a resolution of 1.0 FWHM, Q2
collision-cell activation using rolling collision energy and
nitrogen as collision gas, and recording of the fragments in
the Q3 linear ion trap. Product ion spectra were charge-
state deconvoluted to allow interpretation.
Results and Discussion
Overall Strategy for ESI-MS to Detect
and Sequence Peptide–RNA Oligonucleotide
Crosslinks from a Crude Mixture
In our previous studies, the successful MS analysis of
peptide–RNA crosslinks was mainly dependent on the
detection of the crosslinks in the corresponding RP-
HPLC fraction by monitoring the absorbance at 220 nm
(peptide) and 260 nm (RNA). However, performing this
type of detection before MS suffers from a certain
weakness, such as: residual non-crosslinked peptides
within the fractions interfere with, and sometimes pre-
vent, the detection of the crosslinked species in the
MALDI spectrum, especially when only small amounts
of crosslinked material are being investigated.
To overcome this weakness in the detection of
crosslinks derived from native UV-irradiated particles,
we combined, for the first time, on-line nanoLC with
direct detection and subsequent sequencing of
crosslinks in an ESI hybrid triple quadrupole/linear
ion-trap (LIT) mass spectrometer. Coupling nanoLC
directly to the mass spectrometer reduces the amount of
starting material needed by a factor of 20 compared
with capillary LC.
The overall strategy we used for our experiments is
outlined in Figure 1. A crude mixture of peptide–RNA
oligonucleotide crosslinks and non-crosslinked RNA
oligonucleotides derived from (1) native U1 snRNP
particles and (2) [15.5K-61K-U4atac snRNA] complexes
reconstituted in vitro was prepared according to Kühn-
Hölsken et al. [22]. The mixture is injected onto a
nanoLC system equipped with a 300-m ID trapping
column and a 75-m ID separation column of the same
reversed-phase C18 material (Figure 1a).
Peptide–RNA oligonucleotide crosslinks are retained
on the trapping column, whereas the non-crosslinked
RNA oligonucleotides do not bind during an extended
washing period. Bound crosslinks are eluted by back-
flush onto the analytical column and are separated byusing a linear organic gradient. In contrast to our
previous studies, the on-line coupling uses 5 pmol of
starting material—that is, about 1/20th of the amount
of starting material that had been needed for crosslink
analysis in previous studies [21, 22].
The subsequent mass-spectrometric strategy on a
hybrid triple quadrupole/linear ion trap for targeting
the structural features of peptide–RNA crosslinks in a
crude mixture is outlined in Figure 1b and c. The
strategy consists of a two-run LC/MS/MS workflow. In
a first nanoLC/MS/MS run, a precursor ion scan [36]
for m/z 79 (negative-ion mode, ve) is used to selec-
tively detect analytes containing a phosphate moiety;
that is, it will detect both residual non-crosslinked RNA
oligonucleotides and crosslinked peptide–RNA species
(Figure 1b). Purely peptidic compounds, however, will
not be detected. A high-resolution LIT-MS (ve) pro-
vides information about accurate MW and charge state.
A second nanoLC run in positive-ion mode targets
the detected potential crosslinks by MRM [40, 41],
monitoring their expected decomposition from differ-
ent precursor charge states to one of the four possible
RNA nucleobases [m/z 112, 113, 136, 152; (ve); Figure
1c]. MRM transitions are designed assuming both dou-
bly and triply charged precursors in Q1 because the
predominant charge state in positive-ion mode cannot
be safely assumed to be the same as in negative-ion
mode. On detection, a high-quality MS/MS is triggered
to establish the structure of the crosslink. The Q2
collision cell is used to activate precursors for CID
instead of the Q3 linear ion trap. As a consequence, the
resulting MS/MS spectra in most cases deliver informa-
tion about both the crosslinked peptide and the RNA
moiety of the analytes (Figure 1c).
Both negative- and positive-ion-mode experiments
were performed using the same acidic gradient condi-
tions, with formic acid as modifier. Using constant-
gradient conditions we observed retention times to be
reproducible within 60 s for all of the runs in a set. As
a consequence, retention time can be used as an addi-
tional firm criterion for the assignment of chromato-
graphy peaks between the two polarities. This strategy
also allows rapid switching between precursor ion
scanning and MRM experiments in a series of experi-
ments, which is a prerequisite for routine analysis.
It is currently not possible to accurately assess the
sensitivity of this approach for peptide–oligonucleotide
crosslinks because there are no purified standards avail-
able in known quantities. Using synthetic phosphopep-
tides of similar molecular weight, however, we have
established detection limits to be 5 fmol on-column
for both negative-ion-mode precursor ion scanning and
positive-ion-mode MRM experiments with formic acid
as modifier (C. Lenz, unpublished data). The sensitivity
for peptide–oligonucleotide crosslinks in this regime is
therefore expected to be in the low femtomole range for
both polarities.
873J Am Soc Mass Spectrom 2007, 18, 869–881 LC-ESI-MS/MS Analysis of Protein–RNA CrosslinksFigure 1. Schematic representation of the column setup (a) and the two-run LC/MS/MS workflow on
a hybrid triple quadrupole/linear ion-trap mass spectrometer (b, c) used for the identification of
peptide–RNA crosslinks derived from ribonucleoprotein particles. (a) Crude mixtures containing
peptide–RNA crosslinks and both non-crosslinked RNA oligonucleotides and peptides are loaded onto a
nanoLC system. While free RNA oligonucleotides are washed out, crosslinks remain on the trapping
column (valve pos. 1–2) and are eluted by back-flush onto an analytical column (valve pos. 1–6), where
they are subsequently separated. (b) Precursor ion scan for m/z 79 (negative-ion mode,ve) to selectively
detect analytes containing a phosphate moiety. The resulting spectrum shows the precursor ion signal at
the respective retention time. A high-resolution LIT-MS (ve) provides information about accurate MW
and charge state. (c) Targeted LC/MS/MS analysis using MRM detection in positive-ion mode (ve),
monitoring the expected decomposition of potential crosslinks from different precursor charge states to
one of the four possible RNA nucleobases (m/z 112, 113, 136, 152). At the respective retention times, a
high-resolution LIT-MS and MS/MS are triggered to provide sequence information about both the
crosslinked peptide and RNA moiety of the analytes.
ns.
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Precursor ion scan detection. To generate peptide–RNA
heteroconjugates for detection in precursor ion scan-
ning experiments we (1) UV-irradiated U1 snRNP par-
ticles and then treated them with endoproteinase tryp-
sin and RNase T1 or RNases A and T1, and (2) UV-
irradiated [15.5.K-61K-U4atac snRNA] particles
reconstituted in vitro and then treated them with chy-
motrypsin and RNases A and T1. Samples were puri-
fied as described above and the crude mixtures—
consisting of residual non-crosslinked peptides, non-
crosslinked RNA oligonucleotides, and peptide–RNA
oligonucleotide crosslinks—were submitted to on-line
nanoLC-ESI-MS.
Figure 2 shows representative base-peak intensity
chromatograms from precursor ion scan experiments
(m/z 79 in ve) of both samples. The chromatograms
reveal the elution of several analytes: putative peptide–
RNA crosslinks, non-crosslinked RNA molecules,
and/or (when native particles were used as starting
material) phosphopeptides. Treatment with RNase T1
Figure 2. Base-peak chromatograms of LC/MS
form/z 79 in negative-ion mode for native U1 snR
T1 (a, b) or RNases A and T1 (b) and for [
reconstitution in vitro after treatment with chym
with RNases A and T1 show elution profiles wi
derived after hydrolysis with RNase T1 alone
containing species. The inserts show the precur
between m/z 400 and m/z 1800 derived from U
trypsin and RNase T1 at retention time 24.5 min
treated with chymotrypsin and RNases A and
high-resolution LIT-MS scan of the signals mark
molecular weights of the respective precursor ioalone generally produces conjugates with a larger RNAmoiety compared with conjugates derived from treat-
ment with both endonucleases because RNase T1
cleaves the RNA specifically on the 3= side of guanosine
nucleotides (G), whereas RNase A cleaves 3= to cytidine
and uridine (C and U). Accordingly, different patterns
in the LC analysis combined with precursor ion scan-
ning experiments are observed. In the case of native U1
snRNP particles digested with RNase T1 (Figure 2a), the
base-peak chromatogram does not show well-defined
signals, but instead shows relatively unspecific elution
of phosphate-containing species, with a maximum at
around 24 min that exhibits a significant amount of
streaking. In contrast, both the native and the reconsti-
tuted particles treated with RNases A and T1 show
elution profiles with much sharper peaks (Figure 2b
and c) at about 26-, 13-, and 48-min retention times,
respectively.
The inserts in Figure 2a and 2c show examples of the
precursor ion scan signals from the samples U1 snRNP
treated with trypsin and RNase T1 (Figure 2a) and
[15.5.K-61K-U4atac snRNA] treated with chymotrypsin
and RNases A and T1 (Figure 2c) at different time
experiments using precursor ion scan detection
articles after hydrolysis with trypsin and RNase
-61K-U4atac snRNA] complexes prepared by
psin and RNases A and T1 (c). Particles treated
arp peaks, whereas chromatograms of particles
a relatively unspecific elution of phosphate-
n scan signals of phosphate-containing species
radiated U1 snRNP particles hydrolyzed with
nd from [15.5.K-61K-U4atac snRNA] complexes
t retention time of 49.3 min (c) as well as the
arrows to determine the charge states and the/MS
NP p
15.5K
otry
th sh
show
sor io
V-ir
(a) a
T1 a
ed bypoints of the elution, together with the corresponding
mole
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the charge state. It is important to note that under the
conditions used all putative crosslinked precursors
were detected predominantly as their [M2H]2 quasi-
molecular ions in negative-ion mode.
The results of the precursor ion scan experiments for
U1 snRNP particles treated with trypsin and RNase T1
and for [15.5-K-61K-U4atac snRNA] complexes after
Figure 3. Results of the precursor ion scan dete
particles treated with trypsin and RNase T1 (a)
lyzed with chymotrypsin and RNases A and T1 (
as a function of m/z and chromatographic reten
crosslinks and/or phosphopeptides show well-d
residual non-crosslinked RNA oligonucleotides h
Two potential crosslinks at m/z 883.4 and 961.4
[15.5.K-61K-U4atac snRNA] reveals four putative
precursor ion signals appear as [M-2H]2 quasitreatment with chymotrypsin and RNases T1 and A areplotted in Figure 3a and 3b. The signal intensity of m/z
79 detection (ve) is shown as a function of m/z and the
liquid chromatography retention time. Importantly, po-
tential peptide–RNA crosslinks and/or phosphopep-
tides show well-defined retention times because of their
peptide content, whereas residual non-crosslinked
RNA oligonucleotides (that are not completely re-
moved from the trapping column and thus co-elute
for m/z 79 in negative-ion mode for U1 snRNP
[15.5.K-61K-U4atac snRNA] complexes hydro-
gnal intensity ofm/z 79 detection (ve) is shown
time (RT; “heat map”). Putative peptide–RNA
d RTs because of their peptide content, whereas
o defined RTs and appear as streaks in the plot.
be detected in the U1 snRNP; the heat map of
slinks at m/z 890.3, 899.3, 1035.9, and 1045.0. The
cular ions.ction
and
b). Si
tion
efine
ave n
could
crosfrom the analytical column) have no defined retention
876 LENZ ET AL. J Am Soc Mass Spectrom 2007, 18, 869–881time and appear as streaks in the plot. Importantly, the
“streaking effect” is stronger when RNase T1 is used for
generation of oligonucleotides. This is most probably a
result of the increased length of the oligonucleotides
(see above).
MRM and CID-induced fragmentation. On the basis of
the precursor ion scan plot, we set up MRM experi-
ments for those precursors that showed a defined
retention time in the chromatography. The MRM exper-
iments were performed in positive-ion mode. For each
precursor the decomposition from [M2H]2 and
[M3H]3 to each of the four RNA nucleobases is
monitored, i.e., [MnH]n¡ [{111, 112, 135, 151}H].
As a result, eight MRM transitions are monitored for
each precursor.
The predominant charge states observed in the MRM
experiments in positive-ion mode were 2 and 3,
corresponding to the bimolecular nature of the
crosslinks that offers possible protonation sites both at
the peptide and RNA moieties. A dependency of the
charge state on the relative contents of the two struc-
tural moieties seems likely, but more data points need
to be collected to allow a reliable prediction.
MRM traces of m/z 642.6 (3) to m/z 136.1 (native U1
snRNP) and of m/z 892.3 (2) to m/z 136.1 ([15.5.K-61K-
U4atac snRNA] complexes reconstituted in vitro) are
shown in Figure 4a and b, respectively. Q2 collision cell
product ion scans performed at the respective retention
times revealed structural information on the peptide–
Figure 4. Targeted LC/MS/MS analysis using
MRM traces of m/z 642.6 (3) to m/z 136.1 (25.0
after hydrolysis with trypsin and RNase T1 (
crosslinked [15.5.K-61K-U4atac snRNA] complex
and T1 (b).RNA crosslinks (Figures 5 and 6). Typically, informa-tion about the crosslinked peptide moiety can be found
in the lower m/z range of the spectrum, whereas the
higher m/z range reveals information about the
crosslinked RNA moiety.
Figure 5 shows the product ion scan (Figure 5a) and
the charge-state deconvoluted MS/MS spectrum (Fig-
ure 5b) for the putatively crosslinked precursor m/z
642.6 (3) obtained during targeted LC/MS/MS anal-
ysis of native U1 snRNP particles after hydrolysis with
trypsin and RNase T1. The insert in Figure 5a shows the
yp-type fragment-ion series of the crosslinked peptide
from yp1 to yp5, revealing the sequence VDVER, to-
gether with the signals of two RNA nucleotides: c1 (A)
and zr1 (C) (see Figure 5c for structural information).
The deconvoluted MS/MS spectrum in Figure 5b shows
RNA fragments of the crosslinked nucleotides of yr-, x-,
z-, and d-type, revealing the trinucleotide AUC (see
Figure 5c for structural information). The loss of cyti-
dine (m  305) and the subsequent losses of adenine
(m  135), adenosine (m  329), cytosine (m 
111), and the two remaining sugar phosphates identify
uracil as the actual crosslinked RNA nucleobase. More-
over, the absence of ions representing the intact peptide
crosslinked to either adenosine or cytidine supports our
conclusion that U is the actual crosslinked nucleotide.
The m/z values of the ions marked with an asterisk
consistently represent the mass of the remaining RNA
moiety added to the mass of the intact crosslinked
peptide sequence. Thus, the precursor at m/z 642.6 (3)
was unambiguously revealed to be the U1 70K protein,
detection in positive-ion mode. Shown are the
of a crosslink derived from U1 snRNP particles
d of m/z 892.3 (2) to 136.1 (49.5 min) from
ter treatment with chymotrypsin and RNases AMRM
min)
a) an
es afencompassing positions 173–180 (RVLVDVER),
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tween positions 29 and 31 in the U1 snRNA). As the
result of incomplete CID fragmentation, we were not
able to determine unambiguously the actual crosslinked
amino acid. Nonetheless, CID enabled us (1) to identify
the crosslinked protein as such and (2) to narrow down
the crosslinking site to residues 173–175 (RVL). When
performing analyses, especially with the aim of charac-
terizing hitherto non-characterized ribonucleoprotein
particles, such information is of importance because it
allows us, for example, to identify previously unknown
RNA-binding domains. This is of great value even
without knowledge of the exact point of crosslinking in
the peptide. Figure 5c summarizes the results
schematically.
Figure 6a shows the charge-state deconvoluted
MS/MS spectrum for the putative crosslinked precur-
sor at m/z 892.3 (2) derived from [15.5.K-61K-U4atac
snRNA] particles after hydrolysis with chymotrypsin
and RNases A and T1. A b-type fragment-ion series
from b3 to b6 can be observed for the crosslinked
peptide, revealing the sequence SVLP, as well as several
yp-type ions, those marked with hash marks represent-
ing the mass of the remaining peptide moiety added to
the mass of the intact crosslinked RNA sequence (for
asterisks see above). The measured precursor mass
together with the losses of adenine (m  135) and
adenosine (m  329) demonstrate that the peptide is
crosslinked through the uracil rather than the adenine
base. The combination of all these results reveals that
the U4/U6 snRNP specific 61K protein between posi-
tions 263 and 273 (SSTSVLPHTGY) is crosslinked to an
AU dinucleotide (presumably between positions 43 and
44 in the U4atac snRNA). The results are summarized
schematically in Figure 6b.
These results are consistent with those of our previ-
ous studies in which we sequenced, for the first time,
the crosslinked peptide and RNA moieties of these
isolated crosslinks by MALDI-ToF MS/MS [22]. Impor-
tantly, CID used here for structural investigations has
the advantage over MALDI-MS/MS that the neutral
loss fragmentation (98; known to be the dominant
fragmentation during MALDI-MS/MS experiments for
phosphopeptides and which we also observed during
MS/MS of crosslinks) is negligible, so that more intense
ion series, particularly those of the crosslinked peptide
part, are obtained.
The feasibility study described here has thus proven
that our approach is useful for the detection of un-
known crosslinked peptides from a crude mixture and,
importantly, for obtaining structural information about
the crosslinked peptide and RNA moieties.
In general, hydrolysis of the RNA with two endo-
nucleases improves the detection by ESI-MS over
peptide–RNA conjugates with longer RNA moieties,
that is, those derived after digestion with only RNase
T1 (see above). The precursor ion scan plot from the
U1 snRNP particle treated with trypsin and RNase T1
(Figure 3A) showed that non-crosslinked RNA oligo-nucleotides are co-eluting during the entire separa-
tion and that defined signals are derived only from
crosslinks with a non-specific RNase T1 oligonucleo-
tide, such as AUC crosslinked to RVLVDVER. More-
over, when performing experiments with UV-irradiated
[15.5K-61K-U4atac snRNA] complexes treated with en-
doproteinase chymotrypsin and ribonuclease RNase T1,
we were unable to identify the formerly established 61K
crosslink between amino acids SSTSVLPHTGY (posi-
tions 263–273) and the U4atac T1 oligonucleotide
CAUAG (positions 42– 46) [22, 43]. Off-line and on-line
ESI experiments with that particular crosslink purified
in a semi-preparative manner [21] showed no signal
from the crosslink when investigated in the ESI mass
spectrometer (data not shown). We suggest that the
physicochemical properties of the peptide and RNA
part of peptide–RNA heteroconjugates with longer
RNA moieties (number of nucleotides 3) are indeed
too divergent for ESI-MS, at least under our conditions.
Conclusion
We have developed an LC/MS/MS method that allows
the sensitive and specific analysis of substoichiometric
peptide–RNA oligonucleotide crosslinks in complex
mixtures resulting from UV crosslinking experiments of
native RNP particles and RNP particles reconstituted in
vitro. By a combination of enzymatic digestion,
nanoLC, and highly specific MS experiments we were
able to detect and sequence crosslinks in well-described
test systems ([15.5K-61K-U4atac snRNA] and U1
snRNP [43, 44]). The mass-spectrometric analysis on a
hybrid triple quadrupole/linear ion-trap (QqLIT, Q
TRAP) includes a precursor ion scan for m/z 79 in the
negative-ion mode to selectively detect analytes con-
taining a phosphate moiety, followed by a targeted
LC/MS/MS analysis using MRM in the positive-ion
mode to identify the crosslinked species by their expected
decomposition to one of the four possible RNA nucleo-
bases C=, U=, A=, or G= (m/z 112, 113, 136, 152 in ve).
Our approach combines several layers of specificity:
it removes the bulk of non-crosslinked RNA compo-
nents during on-line nanoLC and the configuration of
the MS analysis excludes the detection of non-
crosslinked peptides. In consequence, we detected
hardly any false positives during the analysis. The
two-run LC/MS/MS strategy improves the data quality
over a single-run strategy in which a precursor ion scan
is combined with a product ion scan as described by
Williamson et al. [39]. This is because it (1) admits
different precursor charge states and (2) provides a
faster cycle time compared with a full scan, precursor
ion scan-driven experiment. Thus, MS/MS experiments
are triggered under close-to-optimum conditions,
which in turn allows charge-state deconvolution of the
resulting product ion spectra.
Another benefit is that, as the polarity switch and
product ion scan components are removed from the
precursor ion scan experiment, more cycle time is spent
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during targeted LC/MS/MS analysis is indicated. For details see text.
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Figure 5. Product ion scan (a) and charge-state deconvoluted MS/MS spectrum (b) form/z 642.6 (3)
obtained during targeted LC/MS/MS analysis of native U1 snRNP particles after hydrolysis with
trypsin and RNase T1. Found peptide and RNA fragment ions are assigned in the spectra. RNA
fragmentation nomenclature is according to McLuckey et al. [47]. y-type peptide fragment-ion series
are named yp1 to ypn. Asterisks next to fragments indicate that the measured fragment masses
represent RNA fragments bound to the intact crosslinked peptide moiety. The insert in (a) shows the
enlarged view of the lower m/z region of the spectrum. A schematic representation of the RNA and
peptide sequences of the identified crosslink is given in (c). Observed fragmentation during targetedFigure 6. Charge-state deconvoluted MS/MS spectrum for m/z 892.3 (2) obtained during targeted
LC/MS/MS analysis of reconstituted [15.5.K-61K-U4atac snRNA] particles after hydrolysis with
chymotrypsin and RNases A and T1 (a). The peptide and RNA fragment ions found are assigned in
the spectrum. Fragmentation nomenclature is according to McLuckey et al. [47]. Hash marks next to
fragments indicate that the measured fragment masses represent peptide fragments bound to the
intact crosslinked RNA moieties (for asterisks see legend to Figure 5). A schematic representation of
the RNA and peptide sequences of the identified crosslink is given in (b). Observed fragmentationLC/MS/MS analysis is indicated. For details see text.
880 LENZ ET AL. J Am Soc Mass Spectrom 2007, 18, 869–881on the precursor ion scan itself and on the data-
dependent high-resolution linear ion-trap scans. As a
consequence, a more complete “molecular weight ver-
sus retention time” map (“heat map”) of the sample is
generated. The information obtained can be compared
with corroborating evidence from previous experi-
ments or with a list of computationally predicted
crosslinks generated before the final MRM experiment
in which MS/MS full scans are collected.
In conclusion, the analytical method is highly selec-
tive. Given that the starting material used was about 5%
of that used for previous experiments [21, 22], it also
possesses excellent sensitivity. Moreover, detailed and
reliable structural information of the crosslinks is ob-
tained from the combination of precursor ion scan,
multiple reaction monitoring, and collision cell CID-
MS/MS experiments.
In summary, we conclude that our ESI approach is
highly suitable for the rapid detection of unknown
crosslinked peptides from crude mixtures and the sub-
sequent identification of the crosslinked protein by
MRM-driven LC/MS/MS acquisition. Note that the
entire approach is optimized for detection of
crosslinked proteins. Dual ribonuclease digestion
clearly favors the detection of the crosslinks in crude
mixtures. Because of the short length of the RNA
moiety obtained by this approach, identification of the
corresponding crosslinking site on the RNA is more
challenging at this stage.
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